Amy Dunn, MD

    Amy Dunn, MD

    Pediatric hematology/oncology specialist at Nationwide Children’s Hospital in Ohio
    • Plasma or Recombinant Products for Hemophilia? Tuesday, April 17th, 2018

      For the past half-century, plasma products have been the mainstay for the treatment of patients with hemophilia. In the 1950s, hematologists used large volumes of fresh frozen plasma to stop minor bleeds, and though the development of plasma-derived clotting factor concentrates allowed for more accurate dosing in the 1960s, the hemophilia community was devastated by [...]

    SHARE